Original scientific paper

SENILE MACULAR DEGENERATION AND ALPHA LIPOIC ACID

Suzana Pavljašević orcid.org/0000-0003-2476-1392 ; Clinic of Ophthalmology Health Center Tuzla, B&H
Sanja Sefić-Kasumović ; Private eye clinic “Sefic” Sarajevo, B&H
Jasna Bejtić-Muhović ; General Hospital “Dr. Abdulah Nakas” Sarajevo, B&H

Abstract

Senile macular degeneration or age-related macular degeneration (AMD) is disease with bad prognosis considering the therapy. Aim of this work was estimated visual aquity, as therapy treatment predict parameter of alpha lipoic acid, in patients with age-related macular degeneration. Patients and methods: in this study 38 patients with this disease, were controlled in period from 2010 to 2012 in Eye Policlinic Public Health Center Tuzla and were treated with alpha lipoic acid for one year. Visual aquity was determinated in the begining and one year after (with or without corrections). Alpha lipoic acid was taken once a day in dosis of 300 mg in one year period of time. Results: Gender-females 63,2%, males 36,8% with age-average 67,92 years (51-81 years). Disease was in righ eye in 44,7% in left eye 31,6% and in both eyes 23,7% . Visual aquity was determinated with Snellen’s tablet in 6 m distnace and in the begining of study was 0,31 and in the end of study was 0,36 (χ²=0,03 df=9-10 with asimptomatic significancy). Results are similar with results of other authors for last ten years studies according to patient’s age and gender. Conclusion: Alpha lipoic acid could be recommanded in age-related macular degeneration therapy as mono or combined therapy but should be taken for years.

Keywords

age-related macular degeneration; alpha lipic acid; visual aquity

Hrčak ID:

116981

URI

https://hrcak.srce.hr/116981

Publication date:

31.12.2013.

Article data in other languages: croatian

Visits: 2.606 *